{"id":"https://openalex.org/W4393316355","doi":"https://doi.org/10.1002/cpt.3212","title":"Oral SSTR5 Antagonist SCO \u2010240 for Growth Hormone Stimulation: A Phase I Single\u2010Dose Study in Healthy Individuals","display_name":"Oral SSTR5 Antagonist SCO \u2010240 for Growth Hormone Stimulation: A Phase I Single\u2010Dose Study in Healthy Individuals","publication_year":2024,"publication_date":"2024-03-28","ids":{"openalex":"https://openalex.org/W4393316355","doi":"https://doi.org/10.1002/cpt.3212","pmid":"https://pubmed.ncbi.nlm.nih.gov/38549435"},"language":"en","primary_location":{"id":"doi:10.1002/cpt.3212","doi":"https://doi.org/10.1002/cpt.3212","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cpt.3212","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.3212","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.3212","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061621850","display_name":"Harunobu Nishizaki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Harunobu Nishizaki","raw_affiliation_strings":["SCOHIA PHARMA Inc., Kanagawa, Japan","These authors contributed equally to the present work"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SCOHIA PHARMA Inc., Kanagawa, Japan","institution_ids":[]},{"raw_affiliation_string":"These authors contributed equally to the present work","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113155494","display_name":"Tomoya Kagawa","orcid":"https://orcid.org/0009-0005-2439-4969","observed_orcids":["https://orcid.org/0009-0005-2439-4969"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tomoya Kagawa","raw_affiliation_strings":["SCOHIA PHARMA Inc., Kanagawa, Japan","These authors contributed equally to the present work"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SCOHIA PHARMA Inc., Kanagawa, Japan","institution_ids":[]},{"raw_affiliation_string":"These authors contributed equally to the present work","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003151109","display_name":"Jun Sugama","orcid":"https://orcid.org/0000-0003-4143-0261","observed_orcids":["https://orcid.org/0000-0003-4143-0261"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jun Sugama","raw_affiliation_strings":["SCOHIA PHARMA Inc., Kanagawa, Japan","These authors contributed equally to the present work"],"raw_orcid":"https://orcid.org/0000-0003-4143-0261","affiliations":[{"raw_affiliation_string":"SCOHIA PHARMA Inc., Kanagawa, Japan","institution_ids":[]},{"raw_affiliation_string":"These authors contributed equally to the present work","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068702838","display_name":"Akihiro Kobayashi","orcid":"https://orcid.org/0000-0002-0375-3388","observed_orcids":["https://orcid.org/0000-0002-0375-3388"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Akihiro Kobayashi","raw_affiliation_strings":["SCOHIA PHARMA Inc., Kanagawa, Japan"],"raw_orcid":"https://orcid.org/0000-0002-0375-3388","affiliations":[{"raw_affiliation_string":"SCOHIA PHARMA Inc., Kanagawa, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060762563","display_name":"Yusuke Moritoh","orcid":"https://orcid.org/0000-0001-5252-6264","observed_orcids":["https://orcid.org/0000-0001-5252-6264"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Yusuke Moritoh","raw_affiliation_strings":["SCOHIA PHARMA Inc., Kanagawa, Japan"],"raw_orcid":"https://orcid.org/0000-0001-5252-6264","affiliations":[{"raw_affiliation_string":"SCOHIA PHARMA Inc., Kanagawa, Japan","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103194228","display_name":"Masanori Watanabe","orcid":"https://orcid.org/0000-0003-2751-2666","observed_orcids":["https://orcid.org/0000-0003-2751-2666"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Masanori Watanabe","raw_affiliation_strings":["SCOHIA PHARMA Inc., Kanagawa, Japan"],"raw_orcid":"https://orcid.org/0000-0003-2751-2666","affiliations":[{"raw_affiliation_string":"SCOHIA PHARMA Inc., Kanagawa, Japan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5060762563","https://openalex.org/A5103194228"],"corresponding_institution_ids":[],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":{"value":4200,"currency":"USD","value_usd":4200},"fwci":0.7856,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.69684049,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"115","issue":"6","first_page":"1326","last_page":"1335"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/somatostatin-receptor-5","display_name":"somatostatin receptor 5","score":0.925000011920929},{"id":"https://openalex.org/keywords/growth-hormone-secretion","display_name":"growth hormone secretion","score":0.949999988079071},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.7450000047683716},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9789999723434448},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9440000057220459},{"id":"https://openalex.org/keywords/gallbladder-contraction","display_name":"gallbladder contraction","score":0.9359999895095825},{"id":"https://openalex.org/keywords/insulin","display_name":"insulin","score":0.8029999732971191},{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.9850000143051147},{"id":"https://openalex.org/keywords/pituitary-hormones","display_name":"pituitary hormones","score":0.9869999885559082},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.7820000052452087}],"concepts":[{"id":"https://openalex.org/C2776297358","wikidata":"https://www.wikidata.org/wiki/Q407166","display_name":"Somatostatin","level":2,"score":0.7387029528617859},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5902349948883057},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5644147992134094},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.5613998770713806},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.5424100160598755},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.5274417996406555},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.519747257232666},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.510436475276947},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.489096462726593},{"id":"https://openalex.org/C56191518","wikidata":"https://www.wikidata.org/wiki/Q416997","display_name":"Peptide hormone","level":3,"score":0.43027591705322266},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36973971128463745},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2736585736274719},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.14494046568870544}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005704","descriptor_name":"Gallbladder","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005704","descriptor_name":"Gallbladder","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017481","descriptor_name":"Receptors, Somatostatin","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D019382","descriptor_name":"Human Growth Hormone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064368","descriptor_name":"Healthy Volunteers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/cpt.3212","doi":"https://doi.org/10.1002/cpt.3212","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cpt.3212","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.3212","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},{"id":"pmid:38549435","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38549435","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1002/cpt.3212","doi":"https://doi.org/10.1002/cpt.3212","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cpt.3212","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.3212","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4393316355.pdf","grobid_xml":"https://content.openalex.org/works/W4393316355.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W1689971274","https://openalex.org/W1947952978","https://openalex.org/W1987603681","https://openalex.org/W2015256197","https://openalex.org/W2035490031","https://openalex.org/W2038018445","https://openalex.org/W2050346528","https://openalex.org/W2314616590","https://openalex.org/W2398993657","https://openalex.org/W2611063944","https://openalex.org/W2623487808","https://openalex.org/W2791224496","https://openalex.org/W2889994902","https://openalex.org/W2890688238","https://openalex.org/W3118257031","https://openalex.org/W4206989655","https://openalex.org/W4213207951","https://openalex.org/W4297381251","https://openalex.org/W4375852389"],"related_works":["https://openalex.org/W7160553543","https://openalex.org/W2038885954","https://openalex.org/W1976521996","https://openalex.org/W2072749059","https://openalex.org/W2008309890","https://openalex.org/W3173663900","https://openalex.org/W1994663521","https://openalex.org/W7095179823","https://openalex.org/W1990573076","https://openalex.org/W2754598094"],"abstract_inverted_index":{"Somatostatin":[0],"inhibits":[1],"endocrine":[2],"and":[3,50,75,79,84,107,133,141,162,167,179,218,220],"exocrine":[4],"secretion":[5,189,212,233],"in":[6,36,64,96,123,145,154,172,213],"various":[7],"tissues":[8],"by":[9],"acting":[10],"on":[11,231],"five":[12],"somatostatin":[13],"receptor":[14],"subtypes":[15],"(SSTR1-5).":[16],"The":[17,53,67,89,100,127,226],"clinical":[18],"effects":[19,29,54,228],"of":[20,30,55,60,81,91,137,177,194,229],"SSTR5":[21,34,208],"antagonism":[22,209],"remain":[23],"unknown.":[24],"Herein,":[25],"we":[26],"evaluated":[27,63,95],"the":[28,146,192,200,203],"SCO-240,":[31],"an":[32],"oral":[33,58,223],"antagonist,":[35],"healthy":[37,48,65],"individuals.":[38,52,66,169],"This":[39],"randomized,":[40],"single-center,":[41],"double-blind,":[42],"placebo-controlled,":[43],"phase":[44],"I":[45],"study":[46,201],"included":[47],"Japanese":[49,166],"White":[51,168],"ascending":[56,147],"single":[57],"doses":[59],"SCO-240":[61,104,114,138,155,183,215,230],"were":[62,71,94,139,158,181],"main":[68],"outcome":[69],"measures":[70],"safety,":[72],"tolerability,":[73],"pharmacokinetics,":[74],"pharmacodynamics":[76],"(gallbladder":[77],"contractions":[78,174],"levels":[80,90,176,193],"serum":[82],"insulin":[83,178],"plasma":[85],"glucagon-like":[86],"peptide-1":[87],"(GLP-1)).":[88],"pituitary":[92,196],"hormones":[93],"our":[97],"exploratory":[98],"analysis.":[99],"results":[101],"indicated":[102],"that":[103,207,235],"was":[105,115,216],"safe":[106,217],"well-tolerated":[108,219],"at":[109],"all":[110],"tested":[111],"doses.":[112],"Oral":[113],"readily":[116],"absorbed,":[117],"with":[118],"its":[119],"systemic":[120],"exposure":[121],"increasing":[122],"a":[124,239],"dose-dependent":[125],"manner.":[126],"median":[128],"time":[129],"to":[130,205],"maximum":[131],"concentration":[132],"mean":[134],"terminal":[135],"half-life":[136],"3-4":[140],"10.2-12.6":[142],"hours,":[143],"respectively,":[144],"dose":[148],"section.":[149],"No":[150,170],"clinically":[151],"meaningful":[152],"changes":[153],"pharmacokinetic":[156],"profiles":[157],"observed":[159],"between":[160,165],"fed":[161],"fasted":[163],"or":[164,175],"increase":[171],"gallbladder":[173],"GLP-1":[180],"detected.":[182],"induced":[184],"robust":[185,227],"growth":[186],"hormone":[187],"(GH)":[188],"without":[190],"altering":[191],"other":[195],"hormones.":[197],"In":[198],"conclusion,":[199],"is":[202],"first":[204],"demonstrate":[206],"stimulates":[210],"GH":[211,232],"humans.":[214],"exhibited":[221],"once-daily":[222],"dosing":[224],"potential.":[225],"suggest":[234],"it":[236],"may":[237],"be":[238],"treatment":[240],"option":[241],"for":[242],"GH-related":[243],"disorders.":[244]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2024-03-30T00:00:00"}